Results from the 2016 study that benchmarks adoption and impact of patient-centric initiatives in drug development. This research aimed to measure the impact of patient engagement across research and development. This is the first-of-its-kind research to understand industry adoption of patient-centric initiatives. The survey instrument was refined in 2022.